Biotech R&D department is supported by a group of competent scientist having expertise in the field of Cell culture, fermentation, purification and analytical testing. Our exceptionally talented teams use their combined expertise to make sure that the recombinant therapeutics are characterised and from validated processes. The R&D labs are fully equipped with most advanced instruments for extensive physico-chemical and bioanalytical product characterization. Diversified talent pool of scientists in R&D plays a pivotal role of developing products, which are transferred to manufacturing facility for commercial production. Starting with biosimilars, the progression is structured to develop hormones, antibodies and proprietary and innovative recombinant biopharmaceuticals in various thrust areas. Biotech R&D has successfully developed 5 molecules which are at different stages of commercialization.
BSV's Biotech R&D has capabilities to develop complex biosimilars and first in world recombinant protein human therapeutics in injectable forms. BSV's Biotech R&D efforts are directed towards biopharmaceutical drug development through 4 principal domains:
Our molecular biology group is constantly engaged in path breaking research for discovery and development of various therapeutic proteins utilizing recombinant DNA technology. These include:
BSV has a strong development team with following expertise:
Our scientists undertake toxicology and pharmacology studies and provide assurance of safety in molecules under investigation. We plan, develop and work based on global regulatory requirements.
The Biologics team has several years of experience in recombinant hormones and antibodies.
Biotech department is equipped with specialized equipment to carry the development and analysis of :
Development is well supported by in-house analytical infrastructure such as: